Market Share of Insulin Pens Industry
The insulin pens market is consolidated, with three significant manufacturers holding the global market presence and the remaining manufacturers confined to the other local or region-specific manufacturers. Mergers and acquisitions or other partnerships within the insulin pens market are limited, as every company manufactures its insulin pens to be compatible with its portfolio of medications.
Insulin Pens Market Leaders
-
Novo Nordisk
-
Sanofi
-
Eli Lilly
-
Biocon
-
Julphar
*Disclaimer: Major Players sorted in no particular order